Business Segments Takeda Pharmaceutical Company Limited

Stocks

Delayed Japan Exchange Other stock markets 02:30:00 2026-07-15 EDT			5-day change	1st Jan Change
5,288.00 ^JPY	-0.73%		-2.99%	+9.37%

10:23pm	Taiwan's Bora Pharmaceuticals in potential $2.5 billion collaboration with Insilico Medicine	RE
07-13	Takeda, Indonesian Government Launch Program to Build National Plasma Ecosystem	MT

Breakdown by Business Segment (JPY)

Fiscal Period: March	2022	2023	2024	2025	2026
Pharmaceutical Products
Pharmaceutical Products	3,569B	4,027B	4,264B	4,582B	4,506B
Total Assets	13,178B	13,958B	15,109B	14,248B	15,512B
Interest Expense	-122B	-117B	-115B	-130B	-148B
Income Tax Expense	72.4B	58.05B	-91.41B	66.94B	9.77B
CAPEX	-186B	-634B	-175B	-201B	-176B
EBT	303B	375B	52.79B	175B	-142B
Gross Profit	-	-	-	-	-
D&A	555B	639B	695B	721B	679B
Operating Income	461B	491B	214B	343B	6.22B
Net Income	230B	317B	144B	108B	-152B
Prescription Drugs	-	-	-	-	-
D&A	-	-	-	-	-
Operating Income	-	-	-	-	-
Non-Prescription Drugs
Consumer Healthcare	-	-	-	-	-
D&A	-	-	-	-	-
Operating Income	-	-	-	-	-
Medicinal Chemicals and Botanical Products
Others	-	-	-	-	-
D&A	-	-	-	-	-
Operating Income	-	-	-	-	-

Geographical breakdown of sales (JPY)

Fiscal Period: March	2022	2023	2024	2025	2026
United States	1,714B	2,104B	2,196B	2,380B	2,165B
Total Assets	6,664B	7,560B	8,224B	7,655B	7,717B
Europe and Canada	739B	843B	967B	1,055B	1,146B
Total Assets	1,515B	799B	861B	800B	1,019B
Total Assets	-	792B	885B	873B	988B
Japan	659B	512B	451B	418B	433B
Total Assets	401B	373B	366B	317B	281B
Latin America	128B	160B	198B	236B	254B
China	-	-	-	192B	195B
Other	68.94B	95.18B	118B	129B	134B
Total Assets	1,278B	1,259B	1,362B	1,330B	1,405B
Asia (Excluding Japan & China)	-	-	-	99.39B	98.67B
Russia/CIS	62.06B	88.43B	72.59B	72.36B	79.72B
Asia (Excluding Japan)	197B	225B	261B	-	-